to get a warrant and it wasn't the first time they have tamed such a secret pfizer warrant and it's a whistle blower bill benny the fight's a warrant that was issued to the f.b.i. to get data from verizon. that's that's been going on according to the paper anyway since not a two thousand and seven if you look at the top corner top right corner of that order it's thirteen dash eighty that means it's the eightieth order since in this year of two thousand and thirteen but on what basis is the pfizer court granting these surveillance warrants well we can't really know since the legal justifications are kept secret so domestic spying in america is quite literally based on a secret law oregon senator jeff merkley in a democracy understanding how a statute is interpreted is essential to the conduct of our responsibility in forging forging laws and ensuring that the constitutional vision is protected to put an end to secret law senator merkley introduced legislation this week to require the attorney general to quote declassify significant foreign intelligence surveillance court opinions all

not allowed to know what goes on inside a pfizer court the court meets in secret sometimes right here at the district courthouse in washington d.c. that issue secret warrants it right secret legal opinions there is no jury there is no defense which makes you wonder why it's even called a court in the first place the pfizer court was created with the one nine hundred seventy eight four and meanwhile off the hill several organizations have taken up similar fights the a.c.l.u. filed a motion this week to force the pfizer court to reveal its legal opinion behind granting the verizon warrant the electronic frontier foundation has been fighting since two thousand and twelve to declassify certain fi's a court opinions but it shouldn't be this difficult senior obama administration officials have promised to make the legal opinions available in two thousand and eleven the former assistant attorney general of the united states lisa monaco promised members of the senate intelligence committee that she would quote work to ensure that the department continues to work to make this important body of

john clark says his people found counterfeit versions of 60 different pfizer drugs from last year. that's up to 20 from 2008. >> the better counterfeiters might put in 10, 20 even 30% of the active pharmaceutical ingredient that's supposed to be in the medicine. >> reporter: they test,0 thousas of products a year. it found fake cancer, fake heart, fake cancer drugs and even fake chapstick. >> they will do a number of testing. fp the packaging doesn't demonstrate it's counterfeit then they go to the medicine itself. >> reporter: this is an audio clip that pfizer gathered. >> we can still make 50,000 pill a month. and that's by hand. >> reporter: the company shares information with law enforcement which conducts the actual raids and makes arrest. those counterfeiters were caught but plenty are not. >> joining me now from fda headquarters dr. margaret hamburg. do you know of actual harm of someone taking these medications? >> absolutely. these products can have none of the active ingredient that people need. they can have too much or too little. they can have toxic ingredients. they c

you have the pfizer court signing off. you have congress written in. you do have the law, but you look at all three checks and pfizer court approves almost everything. you get the intelligence committee knowing about this, but the rest of us don't really. including a lot of other people in congress. and then the law, there's just a lamen reading that section wouldn't think, oh, okay, this is what they are authorizing to vacuum up this data. now it's out. now we can have the debate and argue about whether the benefits are worth the risks. >> we'll be right back after this. america's beverage companies voluntarily removed... full-calorie soft drinks from schools. and we replaced them... with lower-calorie options, and smaller portion sizes. now, there are ninety-percent fewer beverage calories in... schools nationwide. it's just one of the ways we're helping everyone make more... balanced choices everyday. to learn more, visit deliveringchoices.org. >>> we're back with more with rich lowrie. >> i've been so wrong about hillary clinton so many times. i di

pfizer is the first company to win such a case against generic drug- makers. it's expected to encourage more patent suits in the future. in an attempt to prove a naysayer wrong, the ceo of herbalife funded a survey to find out how many americans buy the company's nutritional products. according to herbalife, in a study by nielsen, close to 8 million people in the u.s. bought items in the last 3 months. hedge fund manager bill ackman accused the company of running a pyramid scheme with most independent salespeople losing money. ackman took a $1 billion short against herbalife shares at the end of last year. the stock rallied nearly $2 yesterday. mark zuckerberg is facing facts. at the social media company's shareholder meeting, the ceo heard from angry investors who lost money in the company's ipo. the stock priced in at $38 and is now trading around $23. zuckerberg assured investors that mobile ads are going strong and that he still believes in the company. meanwhile, this week facebook is making big news with one little symbol: the site has added a hashtag si

and i think pfizer's a very good company with a good yield. you're not going to go wrong with either, so those who asked, split the difference or whatever. if you want to take down some zoetis, i bless it. if you want to keep your pfizer, i bless that, too. it's up to you. peter in new york. peter. >> caller: big boo-yah to you, sir! >> thank you. >> caller: reason for the call, we love your show, we value your opinion, i'm a shareholder of groupon. i own it lower than this. buy, sell or hold? >> okay, i'm not a huge fan of groupon, but i've also -- ever since andrew mason left, you know, jim's mason -- no, ever since mason left -- >> sell, sell, sell! >> -- you know what? i've decided kind of a mixture, but the stock was up 10% today. i'd say let it come in if you really like it, but i do like the new managers very much, but they are interim managers, but groupon's not a short, let's put it that way. it was a screaming short. it's not a short anymore. donna in texas, please. donna. >> caller: hi, cramer. this is donna. >> hi. >> caller: i'm i

pfizer trades at 13 times. game and at least selling some premium here to do that. >> thank you. you can catch more "options action" 5:30 p.m. eastern time. coming up next, we're getting a leg up at the open with our top trades for tomorrow. plus, the hottest trades on the planet keep losing steam here. the japan sell-off intensifying today, and fears for deeper losses keep on mounting. a look at how much lower we could go. that's next. ♪ [ cows moo ] [ sizzling ] more rain... [ thunder rumbles ] ♪ [ male announcer ] when the world moves... futures move first. learn futures from experienced pros with dedicated chats and daily live webinars. and trade with papermoney to test-drive the market. ♪ all on thinkorswim. from td ameritrade. [ agent smith ] i've found software that intrigues me. it appears it's an agent of good. ♪ [ agent smith ] ge software connects patients to nurses to the right machines while dramatically reducing waiting time. [ telephone ringing ] now a waiting room is just a room. [ static warble

and i think pfizer's a very good company with a good yield. you're not going to go wrong with either, so those who asked, split the difference or whatever. if you want to take down some zoetis, i bless it. if you want to keep your pfizer, i bless that, too. it's up to you. peter in new york. peter. >> caller: big boo-yah to you, sir! >> thank you. >> caller: reason for the call, we love your show, we value your opinion, i'm a shareholder of groupon. i own it lower than this. buy, sell or hold? >> okay, i'm not a huge fan of groupon, but i've also -- ever since andrew mason left, you know, jim's mason -- no, ever since mason left -- >> sell, sell, sell! >> -- you know what? i've decided kind of a mixture, but the stock was up 10% today. i'd say let it come in if you really like it, but i do like the new managers very much, but they are interim managers, but groupon's not a short, let's put it that way. it was a screaming short. it's not a short anymore. donna in texas, please. donna. >> caller: hi, cramer. this is donna. >> hi. >> caller: i'm i

exchange, all, half or none for the offering that is being offered by pfizer next week. if you have a thought as to the -- >> let me opine on both companies. i think that animal health care is a powerful multi-year growth and pfizer is a good company with a good yield. you are not going to go wrong with either. for those that say split the difference or whatever. if you take the offer or keep it, i bless it. peter in new york, peter? >> caller: big, booyah to you, sir. >> thank you. >> caller: reason for the call, we love your show and value your opinion. i'm a shareholder of groupon, i own it lower than this, buy, sell or hold? >> okay, i'm not a huge fan of groupon, but ever since anthony -- andrew mason left -- no, ever since he left, i decided kind of a mixture, but the stock was you have 10%, let it come in if you really like it. i do like the new managers very much, they are interim managers, but it's not a short. to donna in texas. >> caller: i'm interested in learning more about dean foods. what happened and where is it headed? >> we have the spin off it complete

i am sure in the rural state pfizer is a deficit of attention. the rules the agency needs to adoption guarantee that every job in america can harness the power of the internet and do it safely. the rules the agency needs to adoption of our consumers with the information they need to make informed choices. the rules the agency needs to adopt should continue to create the conditions for job creation, innovation, and investment. the fcc made progress on achieving these goals but an awful lot of work remains to be done. thechallenges will emerge chairman must be more than the hors d'oeuvre industry interest. and they are very effective in making their cases. bottom line, long history. you must use the vast statutory authority to advocate for the .ublic interest also the parent and the student, all those without an army of advocates to lobby on their behalf, we are consumed here about people that come to visit us representing wireless this and that, megahertz, bandwidth, whatever, and that is fine, because they are a big part of the puzzle. of what is

legal representation and they're being tricked so they don't know now you have to understand the pfizer lost in canada they've lost in europe but they go to countries where they can't be sued you can't sue from nigeria here you can't sue for mozambique here so you can go to countries where you either have a corrupt government structure or they're coerced or show us that they've constructively manipulated into having this drug as part of their international foreign aid are you see what i'm saying so the women are become just chess pieces in a mouth lucien eugenics game and so you think this goes beyond just a corporation making as much money as it can pushing it on on as many people as they can you the. it actually goes down to this is a modern day form of eugenics that engine aside yes and it's happening here in the u.s. as well yes it is well that's very shocking and we'll definitely follow up this story very disturbing to thank you so much for coming on ready for your time randy short president national spokesman and i'm with the rebecca project on human rights all right thank you all

legal representation and they're being tricked so they don't know now you have to understand the pfizer lost in canada they've lost in europe but they go to countries where they can't be sued you can't sue from nigeria here you can't sue for mozambique here so you can go to countries where you either have a corrupt government structure or they're coerced or show us that they've constructed manipulated into having this drug as part of their international foreign aid are you see what i'm saying so the women are become just chess pieces in a mouth lucien eugenics game and so you think this goes beyond just a corporation making as much money as it can pushing it on on his money people's it can you think it actually goes down to this is a modern day form of eugenics that engine is yes and it's happening here in the u.s. as well yes it is well that's very shocking and it will definitely follow up this story very disturbing thank you so much for. coming on right before your time randy short president national spokesman and i'm with the rebecca project on human rights all right thank you all ri

they're doing under the authority of the pfizer act section seven o two problem is that section didn't exist until july of two thousand and eight yet the prism program started in two thousand and seven according to these documents released by snowden so you know i'm glad to have these conversations to try to figure out what is going on and it's very difficult but i think that the american people need to know we need to decide at least if we want to have something that appears to be a democratic state or representative democratic state in any fashion snowden's very smart i think that he knows exactly what's facing and he said himself he could be persecuted and the espionage act charge extra to the u.s. so i think that he. he has a good head on his shoulders and he's making the right moves brad let's talk about glenn greenwald the journalist who broke this story i do you think there's a chance that the government will come down hard on him potentially charging him as a coconspirator in light of the trend of rosen wiki leaks and what to your personal experience in this story. yeah well wh

government's case last year alone they came in and put forward about eighteen hundred requests the pfizer court approved every single one of them and even the suppose it public officials who are supposed to oversee this program the people in the senate intelligence committee the house intelligence committee even they don't get to see a lot of these decisions and if they have a problem with them there's very little they can do about it they can't tell us they can't really complain about it they can't make these things public there is so much going on here and when you see. barack obama come out and say we've struck the right balance why democrats partisan democrats simply accept that when they didn't accept it surely when george bush came out and said well we're doing the right thing is absolutely remarkable the point is in this party loyalty place it's astounding brad it is and it really is and let's talk about the whistleblower edward snowden who said i mean he said repeatedly that he didn't want to make the leap. about han but rather about what the u.s. government is doing however he kn

national security letter requests is that there's this whole adit additional function underneath pfizer that has been very very broad. broad interpretations of the law that allows for sort of essentially perpetual data gathering and up until now it seems as though those companies were legally prohibited from actually revealing that and so i think that there's tremendous opportunity for us to actually seek clarification around the extent of that company's interaction and really understand better the sort of technical implications and the amount of data that's being revealed and i think that you know we have seen some of the companies come out in a push for that i think obviously well the information while information is still being gathered and received there are a lot of questions remain up in the air will keep you know david when it really gets on these social networks so you can remember for years your privacy is so important to us you know google says that facebook says that it's all nonsense in retrospect doesn't it. there's so much hypocrisy going on in the private sector and in th

they're doing under the authority of the pfizer act section seven o two problem is that section didn't exist until july of two thousand and eight yet the prism program started in two thousand and seven according to these documents released by snowden so i you know i'm glad to have these conversations to try to figure out what is going on and it's very difficult but i think that the american people need to know we need to decide at least if we want to have something that appears to be a democratic state or representative democratic state in any fashion snowden's very smart i think that he knows exactly what's facing and he said himself he could be persecuted in the s.b. . charge extra to the u.s. so i think that he has a good head on his shoulders and he's making the right moves brad let's talk about glenn greenwald the journalist who broke this story i do you think there's a chance that the government will come down hard on him potentially charging him as a coconspirator in light of the trend of rosen wiki leaks and what to your personal experience in this story. yeah well what the gov

can you throw up a chart of pfizer after hours? i'm sorry to throw a curveball here but we saw that pfizer to your point grasso earlier, had announced this $10 billion stock buyback. here we go again. >> right. >> the market had come in. now they announce a bit of a buyback. look at what the stock is doing after hours. 1.5%. this being one of those catalysts for why the stock market was doing so well because you had company after company coming with the buybacks. >> i think it's a tremendous reason why the stock market has been doing well. people see that, put your money where your mouth is, and they like to hide behind that like to buy stock where they're soaking up that float. but the truth is if they could find another way to deploy capital or if rates rise and they can't borrow to do their buyback, it will be a huge question. >> these are safe names. here is pfizer, 3.4% dividend yield. they have a $10 billion share re.re repurchase. you don't have a ton of risk. they are trading at 12 times on earnings that will go low single

james the pfizer act where did this is this is this the original sin is probably the wrong phrase and i know there's a long history going back to before world war two but is this the genesis of the much of the problem that we're facing right now well part of it yeah i mean. people don't realize about the face or the face of court actually which was created one thousand nine hundred seventy eight because there are you know the government is always citing. the place the court is if it's you know the supreme court or something that came out of the church commission yeah it was a result of basically as a result of thirty years of venice a illegal spying on the us at the time it was telegrams the sort of the internet of the day and to prevent that from happening again they made n.s.a. go through this court called the foreign intelligence surveillance court which was a good idea but the problem is become what became fairly quickly a rubber stamp in the since one thousand nine hundred seventy eight today the court has only turned the government down once and that one time i'm sorry well the

a couple of stocks, pfizer, for example, and at&t. both decreasing in their weighting in the stock, pfizer because of m&a, at&t because of buybacks. it looks like maybe pfizer hasn't quite settled down yet. but again, no big price moves on either one of them. for the week, it wasn't very pretty. the dow jones industrials average down about 2%. most of the other indices down as well. i would note, maria, the dow transports down 3.4%, a big cyclical name, a little bit of a warning. have a great weekend. >> have a great weekend, bob. thank you very much. more next week. >>> another volatile day in the markets today. we want to break it down with our panel of experts. rob joining us, rebecca, stephanie from the street.com. good to see everybody. thank you so much for joining us. ralph, you are the man of the moment to speak to. you were right and have been right on this market in terms of being bullish. however, we've seen some real volatility. do you want to stay on the sidelines here, or would you be putting money to work after the week

. >> we should mention pfizer. a spin-off from pfizer, an exchange offering.e of the company. used to be part of their business. call it 400 million shares. had been exchanged did pfizer accepted shares of pfizer stock in exchange for 400 million of zoetis common stock. a lot of people planning the exchange offer in the risk arbitrage community and the likes. usually they go well. >> how were you profiting from that? >> plan, a lot of people long pfizer, frankly. >> right. i was going to say, pfizer alone is better so a fantastic animal health company, i thought this was good financial engineering. you know how i hate up monday mornings? down monday is a license to pick away. i get more bullish. >> that's what you do. you mentioned apple in your note. jeff friday's cutting their target. getting close to the three handle. >> it was better when interest rates were lower because it was an interesting bond market. >> love to look at apple bonds. got to be down 12% on those, easy, right? got to be in the 80s. >> secret of this new apple is playing the bond market.

they are selected by the chief justice to sit on the pfizer court for a.of time -- the fisa court for a period of time. >> i guess the crux of my question -- would there be a way that if you did not get the answer you wanted from a certain judge, could you go to another fisa court judge and ask for another opinion? verythink that would be difficult to do, because the staff does a great deal of the prep work, and they are going to recognize when they have thrown something back. if you have not made changes to correct the deficiencies that cause them to throw it out, i guess is they will throw it back again. >> one of the things a lot of people do not understand, that i think you have also discussed, is the rita had -- the rita had document. a lot of focus has been made on the fact that, as my colleague mr. thompson said, the court is a rubber stamp, but they do have an opportunity to review the documents prior to rendering a decision. >> they do. it is by no means as a rubber stamp. they push back a lot. these are very thick applications that have a lot in

that is the former foreign minister and the supreme leader's international affairs and pfizer. -- advisor. neither are polling well. is the only reformist running after he with drew. isis also a cleric, but he running with the backing of some powerful man. this includes the head of the reformist movement and the former president. a by the help of people come national unity, and consensus of authorities we could overcome sanctions. >> he was the nuclear negotiator, and negotiating the race is now the job of voters, who will decide what they want, reform or negotiations. >> it has long been known our bodies make vitamin d when exposed to the sun. there is another surprising benefit. >> holidaymakers have long --ght out the sun area did taught out the sun. researchers have discovered another important process. >> there is a substance we have discovered to be present in large quantities in the skin, and when ultraviolet hit the skin, it is moved into the bloodstream. not produced a small and particularly long-lasting fall in blood pressure. >> high blood pressures is one of the leading causes

down, as you see pretty dramatically hewlett, pfizer, microsoft, united healthcare.merican express down about 68 the real-estate shares of cooper tire. that will do it. >> reporter: you wake up in the morning. looking at my stock today. you're seeing shares it jump big time, up 41 percent going into the closing bell. over and in india, paulo tire saying it is going to buy usa cooper tire and rubber, two and a half billion dollar deal. it makes it the seventh largest in the world. cooper tire by itself was the 11th largest. moving up in the ranks. as i noted, two and a half billion dollar deal. it is a 43% premium, yesterday's close. that is why you're seeing that stock jumped. as far as volatility, you're absolutely right. seven of 11 trading days we have had these 100. on more swings. in the first five months we really had that. so it shows you the last couple of weeks have been very busy with volatility. liz: and we need to watch very closely because things seem to be happening. hitting very close lola's course for the s&p 500. everyone is watching out for the next

jim, i have 550 shares of pfizer to my account. >> are you in good shape. i like pfizer, it's not my favorite in the group, though. my favorite is glaxo smith kline. gsk. i think that's the better one. dean in california. >> caller: hey, jim. i'm laying here on the couch with the flu boo-yah. >> oh, sorry to bother you. >> listen, i bought kmp a while back. when it went up in the 90s, i thought it was real cotton, since then, it's been pounded mersly. >> how many of these can you fight at once, if the stock drops to 80, going right back in, it's just the rotation has been so vicious to this group. you can really only own one without getting too hammered. and that, ladies and gentlemen, is the conclusion of the lightning round! >>> coming up, innovative tumors are changing the landscape in the fight against cancer. tonight, cramer speaks with the ceo of biomarin to hear what its results of the latest study may mean for the future. [ cows moo ] [ sizzling ] more rain... [ thunder rumbles ] ♪ . >>> two weeks ago, i told you the american society of clinical onc

people in the intelligence area can overreach and it's an invitation to overreach when you have a pfizer court that operates in secrecy as it much and issues warrants and declarations that are kept secret and the congressional oversight is not adequate, in my view. there's a civil liberties and privacy protection board set up but it was never really operating until 2012. >> when the president says they are under very strict supervision of all three branchs of government. he also says they why they have congressional oversight, his words. these are the folks you vote for as you representatives in congress and they are being fully briefed. that's what the president said but he also went onto said for those that are critical he is welcoming a debate on this. perhaps in response to the questions of whether the transparency he promised whether it's existing. >> i welcome the debate as well. i think it's important not to debate whether he's done something improper because it appears that everything this government has done has been consistent with the law but whether the law ought to be change

pfizer drugs last year.dust, wall board, flour, things of that nature. the better counterfeiters might put in 10, 20, even 30% of the active pharmaceutical ingredient that's supposed to be in the medicine. >> reporter:. >> the pfizer lab in connecticut tests thousands of pfizer products and packaging a year. it's found fake cancer medicine, fake vaccine, fake heart and cholesterol drugs, even fake chapstick. >> they'll start with the packaging, do a number of tests to see authentic versus the counterfeit or versus the questionable one, and if the packaging doesn't demonstrate that it's counterfeit, then they actually go to the medicine itself. >> this is an audio clip that pfizer gathered as part of an undercover investigation. >> we can still make 50,000 pills a month. >> wow. >> and that's by hand. >> the company shares the information with law enforcement, which then conducts the actual raids and makes arrests. those counterfeiters were caught, but plenty are not. and joining me now from fda headquarters,

this program, by the way, is fully overseen not just by congress but by the pfizer court. >> there areeport by "the guardian" that the nsa and fbi have access to most of the big internet providers including microsoft, google, and apple. the president told americans not to worry. >> with respect to the internet, emails, this does not apply to u.s. citizens or to people living in the united states. >> the president said he believes that these two top-secret programs and other strike the right balance between security and privacy. he challenged members of congress who disagree to speak up. on both sides of the aisle they are. today, cnn's dana bash spoke with democratic senator mark udall who sits on the senate select intelligence committee. >> the president said, wait a minute, members of congress knew about, this they were authorized and briefed on it. if they had problems they should have raised questions. >> i did raise questions. >> what happened? >> i went to the floor. i offered amendments. i did everything possible short of leaking. >> that's the cash. both programs are secret. th

right here that's probably going to stay there for a while until maybe my competition comes in the pfizer rep was here and put this back up nearly to get things back that only is a little games you play it so you're rhotic drug reps up at the same time i'm sending anonymous mailers on zoloft whether approved or unapproved i'm leaving off our cards everywhere what i'm trying to do is over like this three month period make a sort of kind of make it seem like it's naturally occurring as a loss as a big deal this off is the new drug to be using i think many reps know that doctors think about what they do in terms of cases so if you can get a physician talking about a case they start to sell themselves let's say dr w. comes up to me and say a house offered for he says it's going to use it for depression your patients say of course is indicated for depression and so using anywhere else no i've done nothing illegal. now let's say by chance that debbie says well you know you do use it for some patients with panic disorder that's an off label use of the drug i say well i got your signature for sam

pfizer says it no longer would hold any ownership interest in zoetis. joining us from chicago jim yorio are tjm institutional services. welcome back. jpmorgan downgrading deere from the u.n. weight to neutral saying a confluence of factors saying u.s. crop fundamentals have passed dierickx up 2% for the one-year period. the question is do you agree or disagree with this downgrade? >> i agree with the downgrade. i read the analyst note and he makes a point about the wet planting season delaying in the midwest. don't get that and then he moves on to higher prices based on dollar valuation juxtaposed against a glut of used equipment being bought and that makes perfect sense. plus, if you look at the chart. to me it looks like 70 on the downside. >> let's move on to morgan stanley, cutting zynga to underweight, the firm citing challenges in mobile and relatively unattractive risk versus reward versus other stocks in the coverage universe. shares of zynga about 70% lower. do you agree or disagree with this downgrade? >> i agree with this downgrade as well. m

pfizer is a remarkable company in that it is creeping up. it plunged off of the lipitor cliff, nothing there, but they have to find in love with pfizer, and my charitable trust owns it, but there is value in the companies that people don't realize. and j. and j., hugely valuable. >> and the gold, where is the pain? where is the pain? there has to be somebody out there. >> i have somebody making a bold call on the gold today. >> suffering mightily, and we moved below 1,200. >> remarkable. >> and down again today, and there it is 1,195. >> we will be exploring that on mad money, because it is either the greatest opportunity or without a doubt the worst market i have come across. >> well, it would be the worst quarter since '62. >> '62. >> what were you doing in '62? do you remember? >> i was getting a capital gains tax cut from president kennedy. larry. >> he was trading even back then. i think that -- i still stand by the gold koins and i don't want to give up on the gold coins, because i like them. i like gold bullion, and it is a free fall

was rewarded with a statutory blank check in the two thousand and eight pfizer amendments act which essentially made illegal everything that the original five was passed to prohibit and it was essentially the act of turning over to the n.s.a. the keys to the internet the backdoor the phone system and since then the n.s.a. has essentially had its way with the rights of the american people and i would just note that the recent disclosures that we've heard about are just the tip of an iceberg and if we knew the full extent of the iceberg i dare say that there would be an earthquake across washington what we've seen i think is just the beginning of a tremor that i do hope very much will grow as we learn more about what the n.s.a. has been doing in secret thank you show here and my apologies for mispronouncing your name. james to what extent is that iceberg show who just identified corporate vs and. you know it's impossible to tell because it's so everything is so secret over there but the the corporate aspect of it when i first started covering the n.s.a. actually right up until nine eleven. there

they are selected by the chief justice to sit on the pfizer court for a.of time -- the fisa court for a period of time. crux of mythe question -- would there be a way that if you did not get the answer you wanted from a certain judge, could you go to another fisa court judge and ask for another opinion? >> i think that would be very difficult to do, because the staff does a great deal of the prep work, and they are going to recognize when they have thrown something back. if you have not made changes to correct the deficiencies that cause them to throw it out, i guess is they will throw it back again. >> one of the things a lot of people do not understand, that i think you have also discussed, is the rita had -- the rita had document. a lot of focus has been made on the fact that, as my colleague mr. thompson said, the court is a rubber stamp, but they do have an opportunity to review the documents prior to rendering a decision. >> they do. it is by no means as a rubber stamp. they push back a lot. these are very thick applications that have a lot in them.

. >> welcome to the cbs sports update presented by pfizer.by two shots to capture his first career pga tour win. phil mickelson shot a final round 67. he finished tied for secondment at the french open in paris, raphael nadal won in straight sets over david ferrer capturing his eighth career french open title. for more sports news and information, go to cbssports.com.e hands, for holding. ♪ feet, kicking. better things than the joint pain and swelling of moderate to severe rheumatoid arthritis. if you're trying to manage your ra, now may be the time to ask about xeljanz. xeljanz (tofacitinib) is a small pill for adults with moderate to severe ra for whom methotrexate did not work well. xeljanz is an ra medicine that can enter cells and disrupt jak pathways, thought to play a role in the inflammation that comes with ra. xeljanz can lower your ability to fight infections, including tuberculosis. serious, sometimes fatal infections and cancers have happened in patients taking xeljanz. don't start taking xeljanz if you have any kind of infection,

they included tobacco giant altria and drug makers pfizer and gloks glaxosmithkline. there's another task force with a bill designed to exempt energy companies from disclosing some of the chemicals they inject underground. the company that sponsored the bill at alec, exxonmobil. five states have introduced or passed versions of that alec bill. alec says "elected legislators," not corporations, "fully control the model legislation process." but nick surgey read alec's operating procedures and found a different story. >> nick surgey: if the corporations do not vote for a model bill, it does not become an alec model. we've seen an example in the telecommunications task force, where the legislators voted 17 to 1 to approve a telecoms bill, they - clearly the will of the legislators was for it to become an alec model. however, the corporations voted and tied 8-8, which meant that it was killed, it didn't become an alec model. >> lisa graves: and i can understand why a corporate lobbyist wants to have an equal say to an elected representative. who wouldn't? but the fact is

i also like pfizer. second half, got to like the pharma names. i think pfizer can go higher. >> does it for us. have a great weekend. look forward to covering the second half of the year. "fast" following "options action" and "power" starts right now. lunchtime, boys. >> dig in. >>> feels like i've been waiting here for hours for this show to begin. the last trading day of the quarter. what a wild ride for the markets. it has been this month, triple-digit swings, volatility. stocks eking out gains. will it be another roller coaster ride? the third quarter? now, defense stocks had a great quarter, a great quarter. many up double digits, a sector that just keeps going higher. despite fears about government, spending cuts, so is defense a way for you to make money, and we're not talking about playing defensively, obviously. different story though, of course, for gold. down about 25% in the past three months. is it time to get back in now? what traders are saying about where gold is going in the second half of the year? sue is down where it's hot and

i also like pfizer. second half, got to like the pharma names.r can go higher. >> does it for us. have a great weekend. look forward to covering the second half of the year. "fast" following "options action" and "power" starts right now. lunchtime, boys. >> dig in. >>> feels like i've been waiting here for hours for this show to begin. the last trading day of the quarter. what a wild ride for the markets. it has been this month, triple-digit swings, volatility. stocks eking out gains. will it be another roller coaster ride? the third quarter? now, defense stocks had a great quarter, a great quarter. many up double digits, a sector that just keeps going higher. despite fears about government, spending cuts, so is defense a way for you to make money, and we're not talking about playing defensively, obviously. different story though, of course, for gold. down about